½ÃÀ庸°í¼­
»óǰÄÚµå
1681377

¼¼°èÀÇ Æú¸® Ä«Å×ÅÍ ½ÃÀå ±Ô¸ð ºÐ¼® : Á¦Ç°º°, Àç·áº°, ÀûÀÀÁõº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)

Global Foley Catheter Market Size Study, by Product, by Material, by Indication, by End Use, and Regional Forecasts 2022-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® 285 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Æú¸® Ä«Å×ÅÍ ½ÃÀåÀº 2023³â¿¡ ¾à 17¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024-2032³â¿¡ CAGR 5.86%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ºñ´¢±â ÁúȯÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ÃÖ¼Òħ½À¼ö¼ú(MIS)¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡, Ä«Å×ÅÍ ±â¼úÀÇ ¹ßÀüÀÔ´Ï´Ù.

¿ä·Î°¨¿°(UTI), ½ÅÀåÁúȯ, Àü¸³¼±ºñ´ëÁõ(BPH)ÀÇ ¹ß»ý·ü Áõ°¡·Î ÀÎÇØ È¿°úÀûÀÎ ¿äµµ°ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ ½ÅÀåÀç´Ü(2023³â)¿¡ µû¸£¸é ³²¼ºÀÇ ¾à 19.1%, ¿©¼ºÀÇ ¾à 9.4%°¡ 70¼¼±îÁö ½ÅÀå °á¼®À» °æÇèÇϰí ÀÖÀ¸¸ç, ÀÌ´Â Æú¸®Ä«Å×ÅÍ¿Í °°Àº Àå±âÀûÀÎ ¹è´¢ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ º¸°í¿¡ µû¸£¸é Àü ¼¼°è¿¡¼­ 1,500¸¸ ¸í ÀÌ»óÀÌ Ã´¼ö¼Õ»ó(SCI)À» ¾Î°í ÀÖÀ¸¸ç, ±× Áß »ó´ç¼ö°¡ ¹æ±¤ °ü¸®¸¦ À§ÇØ ¿äµµ»ðÀÔ Ä«Å×Å͸¦ ÇÊ¿ä·Î Çϰí ÀÖ½À´Ï´Ù.

ÀÛÀº Àý°³Ã¢, ªÀº ÀÔ¿ø±â°£, ºü¸¥ ȸº¹À» À§ÇØ È¯ÀÚµéÀº ÃÖ¼Òħ½À¼ö¼ú(MIS)À» ¼±È£Çϰí ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó MIS ¼ö¼úÀÇ Ã¤ÅÃÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. Æú¸® Ä«Å×ÅÍ´Â MIS ¼ö¼ú¿¡¼­ Áö¼ÓÀûÀÎ ¹æ±¤ ¹è¾×À» Á¦°øÇÏ°í ¼ö¼ú ÈÄ ÇÕº´ÁõÀ» ÁÙÀÌ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¶ÇÇÑ Ç×±Õ ÄÚÆÃ, ¼¾¼­°¡ ÀåÂøµÈ ½º¸¶Æ® Ä«Å×ÅÍ, »ýºÐÇØ¼º ¼ÒÀç µîÀÇ ±â¼ú ¹ßÀüÀº Æú¸®Ä«Å×ÅÍÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» Çâ»ó½ÃÄÑ ½ÃÀå ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­½Ã۰í ÀÖ½À´Ï´Ù.

¾÷°è ÁÖ¿ä ±â¾÷ °£ÀÇ Àü·«Àû Á¦ÈÞ ¹× M&A Ȱµ¿ÀÌ °æÀï ±¸µµ¸¦ Çü¼ºÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 12¿ù Bactiguard Holding AB´Â BD(Becton Dickinson &Company)¿Í Á¦ÈÞÇÏ¿© ¹Ì±¹, ij³ª´Ù, ¿µ±¹, ¾ÆÀÏ·£µå, ÀϺ», È£ÁÖ¸¦ Æ÷ÇÔÇÑ ¿©·¯ ±¹°¡¿¡¼­ Bactiguard ÄÚÆÃ Æú¸® Ä«Å×Å͸¦ ÆÇ¸ÅÇÏ°Ô µÇ¾ú½À´Ï´Ù. ÆÇ¸ÅÇÏ°Ô µÇ¾ú½À´Ï´Ù. À̹ø ÆÇ¸Å °è¾àÀº ½ÃÀå ħÅõ¸¦ È®´ëÇÏ°í ¸ÅÃâ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â 31.62%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, À̴ ÷´Ü ÀÇ·á ÀÎÇÁ¶ó, ¸¸¼º ½ÅÀåÁúȯ(CKD) À¯º´·ü Áõ°¡, ³ôÀº °í·ÉÈ­À²¿¡ ±âÀÎÇÑ °ÍÀ¸·Î ºÐ¼®µË´Ï´Ù. ±×·¯³ª ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·áºñ Áõ°¡, Áß±¹°ú ÀϺ»ÀÇ ±Þ¼ÓÇÑ °í·ÉÈ­, ºñ´¢±â°ú ÀÇ·á¿¡ ´ëÇÑ Á¢±Ù¼º È®´ë¿¡ ÈûÀÔ¾î °¡Àå ºü¸¥ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­¿¡ Æ÷ÇÔµÈ ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷

  • Sterimed Group
  • ANGIPLAST PRIVATE LIMITED
  • HEMC(Hospital Equipment Manufacturing Company)
  • Cardinal Health
  • Advin Health Care
  • AdvaCare Pharma
  • Teleflex Incorporated
  • Bactiguard AB
  • Medtronic
  • B. Braun SE
  • Ribbel International Limited
  • Coloplast Corp

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ Æú¸® Ä«Å×ÅÍ ½ÃÀå : °³¿ä

  • ¼¼°èÀÇ Æú¸® Ä«Å×ÅÍ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2032³â)
  • Áö¿ªº° °³¿ä
  • ºÎ¹®º° °³¿ä
    • Á¦Ç°º°
    • Àç·áº°
    • ÀûÀÀÁõº°
    • ÃÖÁ¾ ¿ëµµº°
  • ÁÖ¿ä µ¿Çâ
  • °æ±âÈÄÅðÀÇ ¿µÇâ
  • ¾Ö³Î¸®½ºÆ®ÀÇ Á¦¾È°ú °á·Ð

Á¦2Àå ¼¼°èÀÇ Æú¸® Ä«Å×ÅÍ ½ÃÀå : Á¤ÀÇ¿Í ºÐ¼® ÀüÁ¦

  • ºÐ¼® ¸ñÀû
  • ½ÃÀåÀÇ Á¤ÀÇ
  • ºÐ¼® ÀüÁ¦
    • Æ÷ÇÔ°ú Á¦¿Ü
    • Á¦ÇÑ »çÇ×
    • °ø±ÞÃø ºÐ¼®
      • °¡¿ë¼º
      • ÀÎÇÁ¶ó
      • ±ÔÁ¦ ±¸Á¶
      • ½ÃÀå °æÀï
      • °æÁ¦¼º(¼ÒºñÀÚÀÇ ½ÃÁ¡)
    • ¼ö¿äÃø ºÐ¼®
      • ±ÔÁ¦ ±¸Á¶
      • ±â¼ú Áøº¸
      • ģȯ°æ
      • ¼ÒºñÀÚÀÇ Àǽİú ¼ö¿ë
  • ºÐ¼® ¹æ¹ý
  • ºÐ¼® ´ë»ó ±â°£
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ Æú¸® Ä«Å×ÅÍ ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ºñ´¢±â ÁúȯÀÇ ÀÌȯÀ² Áõ°¡
    • °í·ÉÈ­ Àα¸ÀÇ Áõ°¡
    • Àúħ½À¼ö¼ú(MIS)ÀÇ ¼ö¿ä Áõ°¡
  • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
    • Ä«Å×ÅÍ °ü·Ã ¿ä·Î°¨¿°Áõ(CAUTI)ÀÇ ¸®½ºÅ©
    • ¾ö°ÝÇÑ ±ÔÁ¦ Áؼö¿Í ǰÁú ±âÁØ
  • ½ÃÀå ±âȸ
    • Ä«Å×ÅÍ ±â¼úÀÇ Áøº¸(½º¸¶Æ® ÄÚÆÃ°ú Ç×±Õ ÄÚÆÃ)
    • ½ÅÈï ½ÃÀå°ú ÀçÅà ÀÇ·á¿¡¼­ÀÇ È®´ë

Á¦4Àå ¼¼°èÀÇ Æú¸® Ä«Å×ÅÍ ½ÃÀå : »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ¹ÙÀ̾îÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷ °£ °æÀï °ü°è
    • Porter's Five Forces ¸ðµ¨¿¡ ´ëÇÑ ÇâÈÄ ¾îÇÁ·ÎÄ¡
    • Porter's Five ForcesÀÇ ¿µÇ⠺м®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû ¿äÀÎ
    • °æÁ¦Àû ¿äÀÎ
    • »çȸÀû ¿äÀÎ
    • ±â¼úÀû ¿äÀÎ
    • ȯ°æÀû ¿äÀÎ
    • ¹ýÀû ¿äÀÎ
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • ÆÄ±«Àû º¯È­ÀÇ µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ ½ÃÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ Á¦¾È°ú °á·Ð

Á¦5Àå ¼¼°èÀÇ Æú¸® Ä«Å×ÅÍ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Á¦Ç°º°(2022-2032³â)

  • ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ¸ÅÃâ µ¿Ç⠺м® : Á¦Ç°º°(2022³â¡¤2032³â)
    • 2 ¹æÇâ Æú¸® Ä«Å×ÅÍ
    • 3 ¹æÇâ Æú¸® Ä«Å×ÅÍ
    • 4 ¹æÇâ Æú¸® Ä«Å×ÅÍ

Á¦6Àå ¼¼°èÀÇ Æú¸® Ä«Å×ÅÍ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Àç·áº°(2022-2032³â)

  • ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ¸ÅÃâ µ¿Ç⠺м® : Àç·áº°(2022³â¡¤2032³â)
    • ½Ç¸®ÄÜ Æú¸® Ä«Å×ÅÍ
    • ¶óÅØ½º Æú¸® Ä«Å×ÅÍ

Á¦7Àå ¼¼°èÀÇ Æú¸® Ä«Å×ÅÍ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÀûÀÀÁõº°(2022-2032³â)

  • ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ¸ÅÃâ µ¿Ç⠺м® : ÀûÀÀÁõº°(2022³â¡¤2032³â)
    • ¿ä½Ç±Ý
    • ¾ç¼º Àü¸³¼± ºñ´ëÁõ(BPH)
    • ô¼ö ¼Õ»ó
    • ±âŸ

Á¦8Àå ¼¼°èÀÇ Æú¸® Ä«Å×ÅÍ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°(2022-2032³â)

  • ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ¸ÅÃâ µ¿Ç⠺м® : ÃÖÁ¾ ¿ëµµº°(2022³â¡¤2032³â)
    • º´¿ø
    • Àå±â¿ä¾ç ½Ã¼³
    • ±âŸ

Á¦9Àå ¼¼°èÀÇ Æú¸® Ä«Å×ÅÍ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°(2022-2032³â)

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´ Áö¿ª
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä« Áö¿ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
    • Teleflex Incorporated
    • Bactiguard AB
    • Cardinal Health
  • ÁÖ¿ä ±â¾÷ ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Medtronic
    • B. Braun SE
    • Ribbel International Limited
    • Coloplast Corp
    • Sterimed Group
    • ANGIPLAST PRIVATE LIMITED
    • Advin Health Care
    • AdvaCare Pharma
    • HEMC(Hospital Equipment Manufacturing Company)

Á¦11Àå ºÐ¼® ÇÁ·Î¼¼½º

  • ºÐ¼® ÇÁ·Î¼¼½º
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ¿¹Ãø
    • °ËÁõ
    • °£Çà
  • ºÐ¼® ¼Ó¼º
KSA 25.04.10

The global foley catheter market was valued at approximately USD 1.74 billion in 2023 and is projected to grow at a CAGR of 5.86% from 2024 to 2032. Market growth is fueled by the increasing prevalence of urological disorders, a growing geriatric population, rising preference for minimally invasive surgeries (MIS), and advancements in catheter technology.

The growing demand for effective urinary drainage solutions is driven by the rising incidence of urinary tract infections (UTIs), kidney diseases, and benign prostatic hyperplasia (BPH). According to the National Kidney Foundation (2023), approximately 19.1% of males and 9.4% of females experience kidney stones by the age of 70, contributing to the demand for long-term urinary management solutions like Foley catheters. Additionally, the World Health Organization (WHO) reports that over 15 million people worldwide live with spinal cord injuries (SCI), a significant portion of whom require indwelling urinary catheters for bladder management.

The adoption of minimally invasive surgeries (MIS) has surged, as patients prefer procedures that result in smaller incisions, shorter hospital stays, and faster recovery times. Foley catheters play an essential role in MIS procedures, providing continuous bladder drainage and reducing postoperative complications. Moreover, technological advancements, including antimicrobial coatings, sensor-equipped smart catheters, and biodegradable materials, have enhanced the safety and efficacy of Foley catheters, further accelerating market growth.

Strategic collaborations and M&A activities among key industry players are shaping the competitive landscape. For instance, in December 2023, Bactiguard Holding AB partnered with BD (Becton Dickinson & Company) to distribute Bactiguard-coated Foley catheters in multiple countries, including the U.S., Canada, UK, Ireland, Japan, and Australia. These distribution agreements are expected to expand market penetration and boost revenue growth.

From a regional perspective, North America dominated the market in 2023, with a revenue share of 31.62%, due to advanced healthcare infrastructure, increasing prevalence of chronic kidney diseases (CKD), and a high aging population. However, Asia Pacific is expected to witness the fastest growth, driven by rising healthcare expenditures, rapid aging populations in China and Japan, and expanding access to urological care.

Major Market Players Included in This Report:

  • Sterimed Group
  • ANGIPLAST PRIVATE LIMITED
  • HEMC (Hospital Equipment Manufacturing Company)
  • Cardinal Health
  • Advin Health Care
  • AdvaCare Pharma
  • Teleflex Incorporated
  • Bactiguard AB
  • Medtronic
  • B. Braun SE
  • Ribbel International Limited
  • Coloplast Corp

The Detailed Segments and Sub-Segments of the Market are Explained Below:

By Product:

  • 2-way Foley Catheters
  • 3-way Foley Catheters
  • 4-way Foley Catheters

By Material:

  • Silicone Foley Catheters
  • Latex Foley Catheters

By Indication:

  • Urinary Incontinence
  • Benign Prostatic Hyperplasia (BPH)
  • Spinal Cord Injury
  • Others

By End Use:

  • Hospitals
  • Long-Term Care Facilities
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Argentina
  • Colombia
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa

Years Considered for the Study Are as Follows:

  • Historical Year - 2022
  • Base Year - 2023
  • Forecast Period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years (2022-2032).
  • Annualized revenue projections and regional analysis for each market segment.
  • Comprehensive geographical landscape analysis with country-level insights.
  • Competitive landscape review, including leading market players.
  • Strategic recommendations for future market approaches.
  • Detailed analysis of market structure and competitive dynamics.
  • In-depth demand-side and supply-side market assessments.

Table of Contents

Chapter 1. Global Foley Catheter Market Executive Summary

  • 1.1. Global Foley Catheter Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Product
    • 1.3.2. By Material
    • 1.3.3. By Indication
    • 1.3.4. By End Use
  • 1.4. Key Market Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Foley Catheter Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory Frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Foley Catheter Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Increasing Prevalence of Urological Disorders
    • 3.1.2. Growing Geriatric Population
    • 3.1.3. Rising Demand for Minimally Invasive Surgeries (MIS)
  • 3.2. Market Challenges
    • 3.2.1. Risk of Catheter-Associated Urinary Tract Infections (CAUTIs)
    • 3.2.2. Stringent Regulatory Compliance & Quality Standards
  • 3.3. Market Opportunities
    • 3.3.1. Advancements in Catheter Technology (Smart & Antimicrobial Coatings)
    • 3.3.2. Expansion in Emerging Markets & Home Healthcare

Chapter 4. Global Foley Catheter Market Industry Analysis

  • 4.1. Porter's Five Forces Analysis
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's Five Forces Model
    • 4.1.7. Porter's Five Forces Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political Factors
    • 4.2.2. Economic Factors
    • 4.2.3. Social Factors
    • 4.2.4. Technological Factors
    • 4.2.5. Environmental Factors
    • 4.2.6. Legal Factors
  • 4.3. Investment & Funding Landscape
  • 4.4. Top Investment Opportunities
  • 4.5. Competitive Landscape & Key Market Strategies
  • 4.6. Regulatory & Policy Framework
  • 4.7. Industry Expert Perspective
  • 4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Foley Catheter Market Size & Forecasts by Product (2022-2032)

  • 5.1. Segment Dashboard
  • 5.2. Market Revenue Trend Analysis (2022 & 2032)
    • 5.2.1. 2-way Foley Catheters
    • 5.2.2. 3-way Foley Catheters
    • 5.2.3. 4-way Foley Catheters

Chapter 6. Global Foley Catheter Market Size & Forecasts by Material (2022-2032)

  • 6.1. Segment Dashboard
  • 6.2. Market Revenue Trend Analysis (2022 & 2032)
    • 6.2.1. Silicone Foley Catheters
    • 6.2.2. Latex Foley Catheters

Chapter 7. Global Foley Catheter Market Size & Forecasts by Indication (2022-2032)

  • 7.1. Segment Dashboard
  • 7.2. Market Revenue Trend Analysis (2022 & 2032)
    • 7.2.1. Urinary Incontinence
    • 7.2.2. Benign Prostatic Hyperplasia (BPH)
    • 7.2.3. Spinal Cord Injury
    • 7.2.4. Others

Chapter 8. Global Foley Catheter Market Size & Forecasts by End Use (2022-2032)

  • 8.1. Segment Dashboard
  • 8.2. Market Revenue Trend Analysis (2022 & 2032)
    • 8.2.1. Hospitals
    • 8.2.2. Long-Term Care Facilities
    • 8.2.3. Others

Chapter 9. Global Foley Catheter Market Size & Forecasts by Region (2022-2032)

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Mexico
  • 9.2. Europe
    • 9.2.1. UK
    • 9.2.2. Germany
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. India
    • 9.3.3. Japan
    • 9.3.4. Australia
    • 9.3.5. South Korea
    • 9.3.6. Rest of Asia-Pacific
  • 9.4. Latin America
    • 9.4.1. Brazil
    • 9.4.2. Argentina
    • 9.4.3. Rest of Latin America
  • 9.5. Middle East & Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. South Africa
    • 9.5.4. Rest of Middle East & Africa

Chapter 10. Competitive Intelligence

  • 10.1. Key Company SWOT Analysis
    • 10.1.1. Teleflex Incorporated
    • 10.1.2. Bactiguard AB
    • 10.1.3. Cardinal Health
  • 10.2. Market Strategies of Leading Players
  • 10.3. Company Profiles
    • 10.3.1. Medtronic
    • 10.3.2. B. Braun SE
    • 10.3.3. Ribbel International Limited
    • 10.3.4. Coloplast Corp
    • 10.3.5. Sterimed Group
    • 10.3.6. ANGIPLAST PRIVATE LIMITED
    • 10.3.7. Advin Health Care
    • 10.3.8. AdvaCare Pharma
    • 10.3.9. HEMC (Hospital Equipment Manufacturing Company)

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦